These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 715710)

  • 41. [Differential behavior of plasma-renin activity in terminal renal insufficiency under stimulation and suppression conditions].
    Löffler G; Rumpf KW; Lowitz HD; Scheler F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1512-4. PubMed ID: 1030033
    [No Abstract]   [Full Text] [Related]  

  • 42. [Plasma profile of free amino acids in children with chronic renal insufficiency undergoing hemodialysis therapy].
    Penza R; Di Bitonto G; Caringella D; De Palo T; Lorusso L; Laforgia N; Falcone C
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1955-9. PubMed ID: 6518104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renin-angiotensin-aldosterone system in patients on maintenance hemodialysis.
    Ivić M; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1987; 41(3):205-13. PubMed ID: 3661237
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blood 17-hydroxycorticosteroids and their elimination during hemodialysis in acute and chronic renal insufficiency].
    Timokhov VS; Ryzhenko VM; Shaposhnikova VV
    Ter Arkh; 1976; 48(10):99-104. PubMed ID: 1024286
    [No Abstract]   [Full Text] [Related]  

  • 45. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lipid content of plasma in patients with chronic renal failure during hemodialysis treatment].
    Dembitskiĭ VM; Malyĭ VN
    Urol Nefrol (Mosk); 1984; (3):57-9. PubMed ID: 6740820
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of tap water on the level of plasma magnesium in patients with terminal stage of chronic renal insufficiency treated by hemodialysis].
    Bazhanova IM; Levitskiĭ ER
    Urol Nefrol (Mosk); 1975; (1):35-8. PubMed ID: 1118971
    [No Abstract]   [Full Text] [Related]  

  • 48. [Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment].
    Neĭmark MI
    Ter Arkh; 1984; 56(9):102-5. PubMed ID: 6569758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Variations of blood glucose and cholesterol in chronic renal insufficiency during hemodialysis].
    Aljama P; Rodríguez-Piñero J; Pérez Cano R; Jiménez Pereperez J; Garrido M
    Rev Clin Esp; 1977 Dec; 147(5):499-501. PubMed ID: 605256
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 51. [Plasma zinc content in patients with chronic renal insufficiency before and after kidney transplantation].
    Babarykin DA; Shul'man OM; Berzin' NI; Chernevskis KhK
    Ter Arkh; 1985; 57(6):101-3. PubMed ID: 3906986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Digoxin-like substance in blood and hypertension in dialysed patients with chronic renal failure].
    Lapiński M; Wocial B; Januszewicz A; Stepniakowski K; Januszewicz W
    Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):655-4. PubMed ID: 1845688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis].
    Akopian AS; Koriakin MV; Golubov AA; Shevchenko AV
    Urol Nefrol (Mosk); 1991; (4):45-50. PubMed ID: 1659015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency.
    Hulter HN; Licht JH; Ilnicki LP; Singh S
    J Lab Clin Med; 1979 Aug; 94(2):223-31. PubMed ID: 458242
    [No Abstract]   [Full Text] [Related]  

  • 55. [Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis].
    Gudim VI; Sigalla P; Ivanova VS; Oldag K
    Vopr Med Khim; 1980; 26(6):742-6. PubMed ID: 7456404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma concentrations of astemizole in patients with terminal renal insufficiency, before, during and after hemodialysis.
    Zazgornik J; Scholz N; Heykants J; Vanden Bussche G
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):246-8. PubMed ID: 2874116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Behavior of creatine in red blood cells and in plasma of children with chronic kidney insufficiency].
    Eggert W; Syllm-Rapoport I; Daniel A; Wolf S
    Helv Paediatr Acta; 1983 Aug; 38(3):281-90. PubMed ID: 6618894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of glucose-free dialyzing solution on the level of lipid fraction in the blood of patients with chronic renal insufficiency treated with programmed hemodialysis].
    Nikiforova NV; Ermolenko VM; Tananaeva IK; Sokolovskaia IV
    Ter Arkh; 1977; 49(7):64-7. PubMed ID: 898079
    [No Abstract]   [Full Text] [Related]  

  • 60. [Study of the plasmatic renin and reno-medullin in chronic uremic patients during extracorporeal hemodialytic treatment].
    Ripa R; Alvisi R; Salzano S; Baggioni GF
    Minerva Med; 1970 Nov; 61(92):5219-33. PubMed ID: 4321215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.